L-dopa

·October 3, 2019

Parkinson’s disease is also present in the blood

Parkinson's disease involves monocytic alterations in the blood. The cells have reduced viability and are unresponsive to specific stimuli, which could have relevant consequences for the progression of Parkinson's. Immune modulation medications may be a new treatment option to inhibit neurodegeneration associated with PD. Read More

Featured Neurology Neuroscience

·August 12, 2019

Estrogen improves Parkinson’s disease symptoms

Selective estrogen treatments appear to reduce symptoms of Parkinson's disease in male mice. The study sheds light on sex-based differences associated with the disease and may provide new therapeutic avenues for treatment. Read More

This shows two head outlines with drawings of brains in them

Featured Genetics Neurology Neuroscience

·July 6, 2019

To cure brain diseases, neuroscientists must collaborate: That’s why I’m giving my data away

Open sharing of scientific data and standard methods will allow researchers to collaborate on projects and accelerate understanding of neurodegenerative diseases. Read More

Featured Neurology Neuroscience Open Neuroscience Articles

·June 13, 2019

Gut Bacteria Interferes with Metabolism of Parkinson’s Drug

Study provides first concrete examples of how the microbiome can interfere with a drug's intended path throughout the body. Read More

Featured Neurology Neuroscience

·July 8, 2018

Discovering Dopamine’s Role in the Brain

Researchers pay tribute to Arvid Carlsson, who was awarded the Nobel Prize for his research into dopamine, and evaluate what his research means to modern neuroscience. Read More